Analyst Ratings for Acer Therapeutics (ACER)

ACER Rating Summary

  |   Expand Research on ACER
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2.9 / 10   Percentile Rank: 24%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/5/2023 H.C. Wainwright Vernon Bernardino Downgrade Neutral
(Buy)		 N/A
(N/A)		 1.14
(0.90)		 -21.05% Details
8/31/2023 Roth/MKM Jonathan Aschoff Downgrade Neutral
(Buy)		 1.50
(N/A)		 0.61
(0.90)		 47.54% Details